1. Home
  2. DAN vs OGN Comparison

DAN vs OGN Comparison

Compare DAN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dana Incorporated

DAN

Dana Incorporated

HOLD

Current Price

$22.35

Market Cap

2.4B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.50

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAN
OGN
Founded
1904
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DAN
OGN
Price
$22.35
$7.50
Analyst Decision
Buy
Hold
Analyst Count
5
4
Target Price
$26.00
$15.75
AVG Volume (30 Days)
1.7M
6.3M
Earning Date
10-29-2025
11-10-2025
Dividend Yield
1.79%
1.07%
EPS Growth
N/A
N/A
EPS
0.39
1.91
Revenue
$9,957,000,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$57.57
$3.92
Revenue Growth
17.78
N/A
52 Week Low
$10.11
$6.18
52 Week High
$22.91
$17.23

Technical Indicators

Market Signals
Indicator
DAN
OGN
Relative Strength Index (RSI) 61.98 46.46
Support Level $22.05 $6.95
Resistance Level $22.91 $7.86
Average True Range (ATR) 0.81 0.35
MACD 0.14 0.12
Stochastic Oscillator 85.32 59.89

Price Performance

Historical Comparison
DAN
OGN

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: